Invesco
EWTX icon

Invesco’s Edgewise Therapeutics EWTX Stock Holding History

Invesco’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.91M Sell
120,932
-17,467
-13% -$602K ﹤0.01% 2232
2026
Q1 		$4.36M Buy
138,399
+62,961
+83% +$1.82M ﹤0.01% 2255
2025
Q4 		$1.87M Buy
75,438
+9,382
+14% +$188K ﹤0.01% 2625
2025
Q3 		$1.07M Buy
66,056
+9,898
+18% +$140K ﹤0.01% 2898
2025
Q2 		$736K Buy
56,158
+8,028
+17% +$116K ﹤0.01% 2989
2025
Q1 		$1.06M Buy
48,130
+4,695
+11% +$123K ﹤0.01% 2809
2024
Q4 		$1.16M Sell
43,435
-21,341
-33% -$679K ﹤0.01% 2861
2024
Q3 		$1.73M Buy
64,776
+42,532
+191% +$846K ﹤0.01% 2663
2024
Q2 		$401K Buy
22,244
+1,098
+5% +$19.2K ﹤0.01% 3369
2024
Q1 		$386K Buy
21,146
+4,618
+28% +$73.4K ﹤0.01% 3446
2023
Q4 		$181K Sell
16,528
-6,447
-28% -$45.3K ﹤0.01% 3586
2023
Q3 		$132K Buy
22,975
+11,252
+96% +$76.5K ﹤0.01% 3684
2023
Q2 		$90.9K Sell
11,723
-140
-1% -$1.18K ﹤0.01% 3744
2023
Q1 		$79.1K Sell
11,863
-1,004
-8% -$9.31K ﹤0.01% 3723
2022
Q4 		$115K Buy
12,867
+969
+8% +$9.08K ﹤0.01% 3803
2022
Q3 		$117K Sell
11,898
-64
-0.5% -$647 ﹤0.01% 3808
2022
Q2 		$96K Sell
11,962
-4,945
-29% -$37.4K ﹤0.01% 3895
2022
Q1 		$164K Buy
16,907
+390
+2% +$5.02K ﹤0.01% 3803
2021
Q4 		$252K Buy
+16,517
New +$297K ﹤0.01% 3690

Other funds holding EWTX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco's EWTX Position: Q2 2026 in Review

Invesco reduced its Edgewise Therapeutics (EWTX) stake by 13% in Q2 2026, selling an estimated $602K and leaving 120,932 shares worth $4.91M. The position accounts for ﹤0.01% of the portfolio, ranked #2232.

Invesco first reported a position in EWTX in Q4 2021 and has held it in 19 quarters since. 223 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • Invesco held 120,932 shares of Edgewise Therapeutics worth $4.91M as of Q2 2026.
  • Invesco sold 17,467 Edgewise Therapeutics shares in Q2 2026, an estimated $602K.
  • Edgewise Therapeutics made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #2232 holding.
  • Invesco first reported a position in Edgewise Therapeutics in Q4 2021 and has held it in 19 quarters since.
  • 223 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.